Standard BioTools Inc.
LAB
$1.29
-$0.04-3.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.76M | 20.22M | 46.72M | 44.97M | 22.49M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.76M | 20.22M | 46.72M | 44.97M | 22.49M |
| Cost of Revenue | 11.13M | 9.17M | 24.81M | 21.71M | 12.12M |
| Gross Profit | 10.63M | 11.05M | 21.91M | 23.26M | 10.37M |
| SG&A Expenses | 28.11M | 29.82M | 37.59M | 34.40M | 24.86M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 45.46M | 44.44M | 76.45M | 69.27M | 44.22M |
| Operating Income | -23.70M | -24.22M | -29.74M | -24.30M | -21.73M |
| Income Before Tax | -18.28M | -23.49M | -33.80M | -26.82M | -25.41M |
| Income Tax Expenses | -609.00K | -119.00K | 272.00K | 118.00K | 39.00K |
| Earnings from Continuing Operations | -17.67M | -23.37M | -34.07M | -26.94M | -25.44M |
| Earnings from Discontinued Operations | -15.79M | -2.66M | -- | -- | -20.27M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -33.46M | -26.03M | -34.07M | -26.94M | -45.72M |
| EBIT | -23.70M | -24.22M | -29.74M | -24.30M | -21.73M |
| EBITDA | -19.71M | -20.04M | -25.78M | -17.93M | -17.33M |
| EPS Basic | -0.09 | -0.07 | -0.09 | -0.07 | -0.12 |
| Normalized Basic EPS | -0.03 | -0.04 | -0.05 | -0.03 | -0.03 |
| EPS Diluted | -0.09 | -0.07 | -0.09 | -0.07 | -0.12 |
| Normalized Diluted EPS | -0.03 | -0.04 | -0.05 | -0.03 | -0.03 |
| Average Basic Shares Outstanding | 380.50M | 378.24M | 374.54M | 371.54M | 372.33M |
| Average Diluted Shares Outstanding | 380.50M | 378.24M | 374.54M | 371.54M | 372.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |